Jackson Creek Investment Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Jackson Creek Investment Advisors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.51M	Buy	+42,663	New	+$1.46M	0.5%	58
2026 Q1	–	Sell	-38,846	Closed	-$1.8M	–	313
2025 Q4	$1.8M	Buy	38,846 +28,170	+264%	+$1.18M	0.53%	60
2025 Q3	$374K	Sell	10,676 -18	-0.2%	-$626	0.11%	245
2025 Q2	$316K	Sell	10,694 -28,988	-73%	-$827K	0.09%	290
2025 Q1	$1.19M	Sell	39,682 -22	-0.1%	-$672	0.38%	146
2024 Q4	$1.14M	Sell	39,704 -1,232	-3%	-$40.8K	0.34%	153
2024 Q3	$1.58M	Buy	+40,936	New	+$1.46M	0.47%	89
2024 Q2	–	Sell	-30,714	Closed	-$1.19M	–	312
2024 Q1	$1.19M	Buy	+30,714	New	+$1.07M	0.43%	66
2021 Q2	–	Sell	-46,575	Closed	-$1.1M	–	311
2021 Q1	$1.1M	Sell	46,575 -1,383	-3%	-$32.9K	0.38%	120
2020 Q4	$961K	Sell	47,958 -82	-0.2%	-$1.6K	0.38%	131
2020 Q3	$1M	Buy	+48,040	New	+$867K	0.45%	45

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Jackson Creek Investment Advisors's COLL Position: Q2 2026 in Review

Jackson Creek Investment Advisors opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 42,663 shares worth $1.51M. The stake represents 0.5% of the portfolio and ranks #58 among its holdings. This is a return to the name: Jackson Creek Investment Advisors previously reported a position in COLL as recently as Q4 2025.

Jackson Creek Investment Advisors first reported a position in COLL in Q3 2020 and has held it in 11 quarters since. The position peaked at $1.8M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Jackson Creek Investment Advisors held 42,663 shares of Collegium Pharmaceutical worth $1.51M as of Q2 2026.
Collegium Pharmaceutical was a new Jackson Creek Investment Advisors position in Q2 2026.
Collegium Pharmaceutical made up 0.5% of Jackson Creek Investment Advisors's portfolio in Q2 2026, its #58 holding.
Jackson Creek Investment Advisors first reported a position in Collegium Pharmaceutical in Q3 2020 and has held it in 11 quarters since.
Jackson Creek Investment Advisors's Collegium Pharmaceutical position peaked at $1.8M in Q4 2025.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.